BG9588

DRUG2 trials

Sponsors

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions

Glomerulonephritis, MembranoproliferativeKidney TransplantationLupus Nephritis

Phase 2

Study Comparing the Safety of BG9588 (Anti-CD40L Antibody) Against Standard Treatment in Kidney Transplantation

CompletedNCT00001857

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Kidney Transplantation

Start: 1999-05-31End: 2000-04-30Target: 50Updated: 2008-03-04

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

CompletedNCT00001789

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Glomerulonephritis, Membranoproliferative, Lupus Nephritis

Start: 1999-06-30End: 2000-05-31Target: 20Updated: 2008-03-04